Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
出版信息
Wkly Epidemiol Rec. 2010 Mar 12;85(11):100-7.
PMID:20229648
Abstract
摘要
相似文献
1
2
Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.
Wkly Epidemiol Rec. 2011 Mar 11;86(11):93-100.
3
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec. 2011 Oct 21;86(43):469-80.
4
Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines.
Wkly Epidemiol Rec. 2009 Oct 9;84(41):432-6.
5
Antigenic and genetic characteristics of influenza A(H5N1)and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines.
Wkly Epidemiol Rec. 2010 Oct 15;85(42):418-24.
6
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec. 2014 Oct 17;89(42):457-64.
7
Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec. 2015 Mar 20;90(12):109-20.
8
Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec. 2016 Mar 18;91(11):133-43.
9
Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
Arch Virol. 2015 Jul;160(7):1729-40. doi: 10.1007/s00705-015-2442-y. Epub 2015 May 12.
10
Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines, February 2009.
Wkly Epidemiol Rec. 2009 Feb 27;84(9):72-6.
引用本文的文献
1
Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine.
Vaccines (Basel). 2024 Jan 29;12(2):138. doi: 10.3390/vaccines12020138.
2
Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
Vaccine. 2012 Feb 14;30(8):1453-9. doi: 10.1016/j.vaccine.2011.12.109. Epub 2012 Jan 9.
3
An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.
Virol J. 2010 Jul 12;7:151. doi: 10.1186/1743-422X-7-151.
Zotero 插件